US Patent 7807692 Antidiabetic oxazolidinediones and thiazolidinediones
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+391 characters)
Article
Patent abstract
Phenoxyphenyl and phenoxybenzyl oxazolidine-2,4-diones and thiazolidine-2,4-diones are agonists or partial agonists of PPAR gamma and are useful in the treatment and control of hyperglycemia that is symptomatic of type II diabetes, as well as dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity that are often associated with type 2 diabetes.
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07807692 Antidiabetic oxazolidinediones and thiazolidinediones US Patent 7807692 Antidiabetic oxazolidinediones and thiazolidinediones
Infobox
Patent Number
0780769200
Patent Number
780769200
Edits on 30 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
078076920
Date of Patent
October 5, 2010
0Patent Application Number
119226280
Date Filed
June 30, 2006
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
078076920
Date of Patent
October 5, 2010
0Patent Application Number
119226280
Date Filed
June 30, 2006
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07807692 Antidiabetic oxazolidinediones and thiazolidinediones
Infobox
Is a
Patent jurisdiction
Patent number
07807692
Date of patent
October 5, 2010
Patent application number
11922628
Date Filed
June 30, 2006
Patent primary examiner
Find more entities like US Patent 7807692 Antidiabetic oxazolidinediones and thiazolidinediones
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
